Synthetically Lethal Interactions of ATM, ATR, and DNA-PKcs

Area of Science:

• Molecular Biology
• Cancer Genetics
• Drug Discovery

Background:

• Synthetic lethality is a genetic interaction where simultaneous defects in two genes lead to cell death.
• The number of identified synthetic lethal interactions is rapidly increasing.
• Ataxia-telangiectasia mutated (ATM), ATM- and Rad3-related (ATR), and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) are key kinases in DNA damage response.

Purpose of the Study:

• To review known synthetic lethal interactions involving ATM, ATR, and DNA-PKcs.
• To highlight the therapeutic potential of targeting these kinases in cancer.
• To discuss the implications of understanding these interactions for predicting treatment outcomes and resistance.

Main Methods:

• Literature review of synthetic lethality.
• Analysis of gene mutations in cancer.
• Examination of clinical trial data for kinase inhibitors.

Main Results:

• The genes encoding ATM, ATR, and DNA-PKcs are frequently mutated in various cancers.
• Specific inhibitors targeting these kinases are progressing through clinical trials.
• Synthetic lethality involving these kinases offers potential therapeutic strategies.

Conclusions:

• Synthetic lethality interactions involving ATM, ATR, and DNA-PKcs are promising for cancer therapy.
• Understanding these interactions can guide the selection of susceptible tumors and predict treatment responses.
• This knowledge aids in developing novel therapeutic approaches and managing resistance mechanisms.